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Insecticide resistance might reduce the efficacy of malaria 
vector control. In 2013 and 2014, malaria vectors from 50 
villages, of varying pyrethroid resistance, in western Kenya 
were assayed for resistance to deltamethrin. Long-lasting 
insecticide-treated nets (LLIN) were distributed to house-
holds at universal coverage. Children were recruited into 2 
cohorts, cleared of malaria-causing parasites, and tested ev-
ery 2 weeks for reinfection. Infection incidence rates for the 
2 cohorts were 2.2 (95% CI 1.9–2.5) infections/person-year 
and 2.8 (95% CI 2.5–3.0) infections/person-year. LLIN users 
had lower infection rates than non-LLIN users in both low-re-
sistance (rate ratio 0.61, 95% CI 0.42–0.88) and high-resis-
tance (rate ratio 0.55, 95% CI 0.35–0.87) villages (p = 0.63). 
The association between insecticide resistance and infection 
incidence was not significant (p = 0.99). Although the inci-
dence of infection was high among net users, LLINs provided 
significant protection (p = 0.01) against infection with malaria 
parasite regardless of vector insecticide resistance.
The launch of the Roll Back Malaria (RBM) program in 1998 by the World Health Organization (WHO), Unit-
ed Nations Children’s Fund, United Nations Development 
Partnership, and the World Bank was a catalyst for renewed 
global commitment to the fight against malaria, leading to 
massive investment (1). There followed a tremendous de-
cline in disease and death caused by malaria, with a 40% 
reduction in the incidence of malaria cases between 2000 
and 2015 and a reduction in malaria-attributable death from 
839,000 in 2000 to 438,000 in 2014 (1,2). This decline has 
been brought about principally by the use of insecticide-
based vector control tools, such as long-lasting insecticide-
treated nets (LLINs) and indoor residual spraying. It is esti-
mated that LLINs have been a key malaria prevention tool 
in sub-Saharan Africa, accounting for ≈68% of the decline 
of clinical cases (3).
Following the massive scale-up of insecticide-based 
vector control, resistance was observed in almost all coun-
tries in sub-Saharan Africa (http://www.irmapper.com) 
(4). Twelve insecticide products (containing pyrethroids, 
organochlorines, organophosphates, or carbamates) are 
available for vector control. Only pyrethroids are used for 
LLINs because they are safe, efficacious against malaria 
vectors, and relatively low cost (5–7).
On a programmatic scale, a 10-fold increase in ma-
laria cases was observed in KwaZulu-Natal, South Africa, 
subsequent to the re-emergence of pyrethroid-resistant 
Anopheles funestus mosquitoes and emergence of malaria 
parasite drug resistance to sulfadoxine/pyrimethamine (8). 
Upon switching to DDT for indoor residual spraying and 
artemether lumefantrine for malaria case management, ma-
laria parasite control was restored with a rapid decline in 
malaria case incidence (8–10). Similar observations were 
made in Uganda, where DDT and pyrethroids were used 
for indoor residual spraying in the presence of resistance; 
as soon as carbamates were deployed, the malaria parasite 
slide positivity rate declined substantially (11).
Malaria interventions including universal LLIN cover-
age, targeted deployment of indoor residual spraying, and 
prompt diagnosis and treatment have been scaled up in 
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western Kenya since the early 2000s. Control tools target-
ing endophagic and endophilic malaria vector mosquitoes 
have been remarkably effective in reducing An. gambiae 
and An. funestus mosquito populations that were known to 
be anthropophilic; these tools have led to lowered malaria 
inoculation rates and consequently >50% declines in ma-
laria disease and death (12–14). In western Kenya, malaria 
prevalence in children <5 years of age declined to ≈30% in 
2006, after which it stabilized or slightly increased (15,16). 
A possible cause of this persistent infection in children is 
insecticide resistance in the local vector population. Con-
cerns that resistance could be compromising malaria vector 
control and, therefore, hampering efforts to lower malaria 
parasite transmission have led to calls for more effective 
insecticide resistance management (17,18).
Population-based active surveillance can complement 
routine passive sentinel surveillance systems by provid-
ing public health data and insights into the complex epi-
demiology of disease. Active infection-detection cohorts 
are studies that involve clearing participants of infections, 
following them up, and testing them at regular intervals, 
regardless of whether they are symptomatic, until the first 
infection appears, at which point the follow-up is discon-
tinued. These types of studies provide estimates of time to 
infection in participants and are useful because they enable 
estimations of various parameters associated with disease 
(19,20). The main advantage of using population-based 
malaria parasite surveillance is that it provides the data 
needed to determine the infection rate and the populations 
at risk for infection (19).
This study was implemented as part of a large, multi-
country program set up to quantify the impact of insecticide 
resistance on the effectiveness of insecticide-based vector 
controls (21). To determine if insecticide resistance altered 
the effectiveness of LLINs in malaria endemic subcounties 
of western Kenya, we conducted population-based malaria 
parasite active infection-detection cohort studies.
Methods
Study Sites
We conducted this study in 4 malaria-endemic subcoun-
ties in western Kenya described previously (22). In brief, in 
2014, the National Malaria Control Programme conducted 
a massive campaign to distribute nets; a mix of PermaNet 
2.0 (treated with deltamethrin) and Olyset nets (treated 
with permethrin) were distributed in the 4 subcounties 
Bondo, Teso, Rachuonyo, and Nyando to meet the univer-
sal coverage threshold of 1 net per 2 persons. Subsequent 
routine distribution was conducted through health facilities 
to pregnant women and children <5 years of age. Twenty 
sublocations (hereafter referred to as clusters) were ran-
domly selected from each of the 4 subcounties where the 
initial insecticide resistance assessment was conducted 
(21,22). After the assessment, the clusters were catego-
rized into 3 groups: those with >80% mosquito mortality to 
deltamethrin or permethrin (categorized as low-resistance 
clusters), those with mosquito mortality <80% but >60% 
(categorized as medium-resistance clusters), and those with 
mosquito mortality <60% (categorized as high-resistance 
clusters). Finally, 13 low- and high-resistance clusters were 
selected in Rachuonyo, 11 in Teso, 16 in Bondo, and 10 in 
Nyando, giving a total of 50 clusters for subsequent stud-
ies. Each cluster had 10–30 villages, each with ≈100 house-
holds. We recruited children 6 59 months of age from 
households immediately around larval habitats that were 
sampled by the entomology teams for assessing insecticide 
resistance; moving out in concentric circles from the larva 
habitats, we recruited study participants until 20 eligible 
and consenting households were enrolled.
Study Design and Sample Collection
Community health workers were trained to use rapid diag-
nostic test kits SD Bioline Malaria Ag P.f/Pan (Standard 
Diagnostics, Gyeonggi-do, South Korea) and CareStart 
Malaria HRP2 (Pf) (Access Bio, Inc., Somerset, NJ, USA) 
and to appropriately administer artemisinin combination 
therapy (Coartem Dispersible [20 mg artemether/120 mg 
lumefantrine], Novartis, Basel, Switzerland) for the treat-
ment of malaria. The study ran September 2013–May 2014 
for cohort 1 and July–December 2014 for cohort 2. Twenty 
children 6–59 months of age were recruited for each clus-
ter within each cohort. Subject to written informed consent 
from the parent or caregiver, 1 eligible child was enrolled 
from each selected household.
At recruitment, all children were treated with a stan-
dard therapeutic dose of artemether/lumefantrine. To verify 
clearance of malaria parasites, 14 days later, thick and thin 
blood smears were taken from children and assessed for 
infection by microscopic examination. Any children whose 
smear results were positive were excluded from follow-up 
analysis. Community health workers visited each child at 
home every 2 weeks to test for infection with malaria para-
sites using rapid diagnostic tests. Children who tested posi-
tive for malaria parasite were treated and excluded from 
further follow-up. LLIN use on the previous night was re-
corded at each visit. Data in the field was collected using 
paper forms and then entered into electronic forms made 
with Microsoft Excel and Access software (Microsoft, 
Redmond, WA, USA).
From July 2013 through October 2013 and August 
2014 through November 2014, we conducted insecti-
cide resistance monitoring in each of the clusters. We 
collected and reared An. gambiae sensu lato (s.l.) mos-
quito larvae and adults and tested them for susceptibility 
to deltamethrin insecticide using the WHO standard test 
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(22). We performed these bioassays with both permethrin 
and deltamethrin at baseline (22), but because mortality 
upon exposure to these 2 insecticides were positively cor-
related (online Technical Appendix Figures 1, 2, https://
wwwnc.cdc.gov/EID/article/23/5/16-1315-Techapp1.
pdf) and mosquito population size was small, only delta-
methrin was used for bioassays in subsequent years. Ethi-
cal approval for this study was obtained from the Kenya 
Medical Research Institute Ethical Review Committee 
(no. SSC 1677).
Data Analysis
We used individual visit data for each child to conduct 
time-to-event analysis to determine incidence rates and 
incidence rate ratios (RRs) using survival analysis and 
Poisson regression models. Children who had >5 weeks 
between visits were censored. Incidence rates and 95% 
CIs were calculated per person-year for each district 
and year.
We used insecticide resistance data (percentage mos-
quito mortality upon exposure to deltamethrin) to dichoto-
mize clusters into high- and low-resistance clusters by us-
ing the median mortality for that year, namely, 88% for 
2013 (clusters with mortality rates >88% were categorized 
as low resistance and those with mortality rates <88% as 
high resistance) and 67% for 2014 (clusters with mortality 
rates >67% were categorized as low resistance and those 
with mortality rates <67% as high resistance). In combined 
analysis of both years, we used the overall median mortali-
ty (82%) to dichotomize clusters into high or low resistance 
for net users and non–net users. Recommended methods 
(23) were used to compute SEs, allowing for the correla-
tion of responses within clusters. We used incidence RRs 
and corresponding 95% CIs to compare incidence rates be-
tween users and nonusers of LLINs and between high- and 
low-resistance clusters. Modification of the effect of net use 
on infection incidence depending on insecticide resistance 
level (mortality to deltamethrin in bioassays) was assessed 
through the inclusion of an appropriate interaction term in 
the regression model. Net use was included in models as a 
time-varying covariate.
We plotted cluster-specific incidence rates for each 
year and cluster-specific RRs for non–net users and net users 
against mosquito mortality with deltamethrin exposure. 
The slope of best-fitting straight lines were determined 
by using linear regression of cluster-specific incidence on 
cluster-specific mosquito mortality.
Results
Active Infection Cohorts 1 and 2
Approximately 1,000 children were recruited into each active 
infection cohort. The median age of children at recruitment 
was 2.5 years for cohort 1 and 2.2 years for cohort 2. For co-
hort 1, each child was followed for 80 days, and a total of 
279 infections were detected; for cohort 2, each child was fol-
lowed for 95 days, and a total of 483 infections were detected 
(Table 1). LLIN use was 81.3% for cohort 1 and 85.7% for 
cohort 2. The overall incidence rate of infection with the ma-
laria parasite was 2.2 (95% CI 1.9–2.5) infections/person-year 
for cohort 1 and 2.8 (95% CI 2.5–3.0) infections/person-year 
for cohort 2. The subcounty-specific infection incidences were 
1.2–3.0 infections/person-year in cohort 1 and 1.8–4.1 infec-
tions/person-year in cohort 2 (Table 2).
In low-resistance clusters, the malaria parasite infec-
tion incidence rate was 4.0 (95% CI 3.2–5.2) infections/
person-year among non–net users and 2.3 (95% CI 2.1–2.5) 
infections/person-year among net users (RR 0.61, 95% CI 
0.42–0.88; p = 0.01). In high-resistance clusters, incidence 
was 5.3 (95% CI 4.0–7.1) infections/person-year among 
non–net users and 2.9 (95% CI 1.7–3.2) infections/person-
year among net users, a 45% reduction (RR 0.55, 95% CI 
0.35–0.87; p = 0.01) in malaria parasite incidence among 
net users (Table 3).
Association between Malaria Parasite Infection  
Incidence and Insecticide Resistance
We found no association between malaria parasite infec-
tion incidence and insecticide resistance when comparing 
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Table 1. Characteristics of cohorts used to detect active malaria 
parasite infections, Kenya, 2013 and 2014 
Characteristic 
Cohort 1,  
n = 989 
Cohort 2,  
n = 969 
Female sex, % (no.) 49 (481) 49 (478) 
Median age, y (range, mo–y) 2.5 (4–5) 2.2 (1–6) 
Average follow-up per child, d 80 95 
No. infections 279 483 
 
 
 
 
Table 2. Incidence of malaria parasite infection by subcounty and cohort, Kenya, 2013 and 2014 
Subcounty Cohort No. clusters No. children 
No. malaria 
episodes 
Total follow-up time, 
person-years 
Incidence, infections/person-year 
(95% CI) 
Bondo 1 16 184 76 35.0 2.2 (1.7–2.7) 
2 16 255 154 58.5 2.6 (2.2–3.1) 
Nyando 1 10 147 33 28.3 1.2 (0.8–1.6) 
2 10 180 83 47.3 1.8 (1.4–2.2) 
Rachuonyo 1 13 192 97 32.2 3.0 (2.5–3.7) 
2 13 208 136 42.9 3.2 (2.7–3.8) 
Teso 1 11 157 73 29.4 2.5 (2.0–3.1) 
2 11 156 110 27.0 4.1 (3.4–4.9) 
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high- and low-resistance clusters. For cohort 1, incidence 
was 2.2 (95% CI 1.8–2.7) infections/person-year among 
children living in low-resistance clusters and 2.0 (95% CI 
1.6–2.4) infections/person-year among children living in 
high-resistance clusters (adjusted RR 0.9, 95% CI 0.5–1.6; 
p = 0.68) (Table 4). For cohort 2, infection incidence was 
2.8 (95% CI 2.4–3.2) infections/person-years among chil-
dren residing in low-resistance clusters and 2.7 (95% CI 
2.4–3.1) infections/person-years among children resid-
ing in high-resistance clusters (adjusted RR 0.8, 95% CI 
0.5–1.2; p = 0.33). After plotting data from 93/100 clusters 
(data from all subcounties and both years), we found no as-
sociation between deltamethrin insecticide resistance and 
malaria parasite infection incidence (Figure 1).
Insecticide Resistance
Mosquito mortality ranged 55%–100% in 2013 and 30%–
98.5% in 2014. The median (25%–75% interquartile range) 
mortality rates were 88% (81%–97%) for 2013 and 67% 
(51%–80%) for 2014 (Figure 2).
Effect of Insecticide Resistance and Net Use  
on Malaria Parasite Infection Incidence
The interaction between resistance (high and low) and net 
use was not significant for either cohort (p = 0.63) (Table 
3). The insecticide resistance stratum did not modify the 
effect of LLIN use on infection incidence.
Discussion
Because of the widespread use of insecticide-based ma-
laria vector control tools, such as LLINs and indoor re-
sidual spraying (3,17,24), insecticide resistance is a ris-
ing concern in sub-Saharan Africa (4). Our study was 
designed to estimate the effect that pyrethroid resistance 
in local malaria vectors had on malaria parasite infection 
incidence in areas of varying levels of insecticide resis-
tance in western Kenya. Net use was 81.3% in cohort 1 
and 85.7% in cohort 2, a small change in net use despite 
the timing of the LLIN distribution campaign (just before 
the beginning of cohort 2). Nets were found to be effec-
tive at preventing infection in low- and high-resistance 
clusters. Even with rises in pyrethroid resistance among 
malaria vectors, nets were shown to be 39% protective 
in low-resistance clusters and 45% protective in high-
resistance clusters. LLINs are still effective in reducing 
malaria parasite transmission because, aside from the in-
secticide’s repellent and toxic properties, nets also act as 
natural barriers that prevent human–vector contact (25). 
Given the positive news that LLINs are still useful in en-
vironments with high levels of insecticide resistance, ma-
laria parasite control programs should continue to provide 
and distribute LLINs and encourage their use in parallel 
with efforts to develop and evaluate new tools (18,26).
We did not find a significant association between 
insecticide resistance and incidence of malaria parasite 
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Table 3. Incidence of malaria parasite infection in net users and non–net users in low– and high–insecticide resistance clusters, 
Kenya, 2013 and 2014 
Parameter 
No. 
children 
Follow-up time, 
person-years 
No. 
infections 
detected 
Incidence, 
infections/person-
year (95% CI) 
Adjusted RR* 
(95% CI) p value 
Low resistance (mortality >82%) 
    
 
 
 Non–net users 175 15.6 63 4.0 (3.2–5.2) 1.00 
 
 Net users 760 182.9 415 2.3 (2.1–2.5) 0.61 (0.42–0.88) 0.01 
High resistance (mortality <82%) 
    
 
 
 Non–net users 129 9.0 48 5.3 (4.0–7.1) 1.00 
 
 Net users 772 167.7 494 2.9 (1.7–3.2) 0.55 (0.35–0.87) 0.01 
Interaction parameter 
    
0.86 (0.48–1.55) 0.63 
Change in incidence per 10% increase 
in mosquito mortality 
    0.96 (0.87–1.06) 0.45 
*Adjusted for district, year, and visit month. 
 
 
 
 
Table 4. Incidence of malaria parasite infection in low– and high–insecticide resistance clusters by year, Kenya, 2013 and 2014* 
Insecticide resistance 
No. 
children 
No. 
malaria 
episodes 
Total follow-
up time, 
person-years 
Incidence, 
infections/person-
year (95% CI)  
Unadjusted Adjusted 
RR (95% CI) p value RR (95% CI) p value 
2013          
 Low resistance 290 114 51.6 2.2 (1.8–2.7) 1.0   1.0  
 High resistance 311 116 59.2 2.0 (1.6–2.4) 0.9 (0.5–1.6) 0.70  0.9 (0.5–1.6) 0.68 
 Per 10% increase in 
 mosquito mortality 
    1.0 (0.7–1.5) 0.99  1.0 (0.7–1.5) 0.98 
2014          
 Low resistance 433 224 80.7 2.8 (2.4–3.2) 1.0   1.0  
 High resistance 460 222 80.9 2.7 (2.4–3.1) 1.0 (0.7–1.4) 0.96  0.8 (0.5–1.2) 0.33 
 Per 10% increase in 
 mosquito mortality 
    1.0 (0.9–1.1) 0.90  1.1 (0.9–1.2) 0.24 
*In 2013, low resistance was defined as mortality >88% and high resistance as mortality <88%. In 2014, low resistance was defined as mortality >67% 
and high resistance as mortality <67%. RR, rate ratio. 
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infection in either year. Concern that insecticide resis-
tance could compromise malaria parasite control has been 
expressed (18,24,27,28), and, with this, the expectation 
that the incidence of infection would be higher in high-re-
sistance areas. The results of our study, therefore, are sur-
prising, considering the failure some countries have had 
in malaria vector control after the development of resis-
tance to the insecticides used in indoor residual spraying 
(8,29). More specifically, studies have reported resistant 
mosquitoes surviving exposure to potent nets (nets able to 
knockdown >80% of susceptible mosquitoes) (30,31); it 
was expected that areas with such mosquitoes would have 
higher malaria parasite infection incidences because the 
mosquitoes live longer and thus are able to spread malaria 
parasite for longer.
Several factors might explain why we did not observe 
a correlation between insecticide resistance and malaria 
parasite infection incidence. First, as previously men-
tioned, LLINs serve as a barrier to prevent human–vec-
tor contact. If the nets are in good condition and are used 
consistently and properly, they reduce the chances of mos-
quito bites and hence malaria parasite transmission (32). 
Second, the WHO tube bioassay does not indicate what 
level of insecticide resistance is expected to lead to vec-
tor control failure, which is a major weakness of the assay 
(33). Therefore, even though we observe insecticide resis-
tance, the mosquito populations might still be susceptible 
to the toxic effects of the chemical doses used on the nets. 
This highlights the need for more quantitative methods for 
monitoring insecticide resistance (33,34). In addition, a 
recent study in deltamethrin-resistant mosquitoes showed 
that sublethal doses of pyrethroids can interfere with para-
site development (35). Even though these mosquitoes do 
not succumb to exposure with insecticides, their ability to 
transmit the malaria parasite is reduced, and therefore, in-
creasing insecticide resistance does not necessarily directly 
and immediately lead to a major increase in incidence of 
malaria parasite infection.
However, our results should be interpreted with cau-
tion. We have already observed instances of mosquitoes 
failing to succumb to control tools, such as in a report 
conducted in the Bungoma district, where resting but still 
bioactive pyrethroid-resistant An. gambiae sensu stricto 
(s.s.) mosquitoes were found inside of LLINs without get-
ting killed or repelled (30). Also, in Benin, as many as 5 
mosquitoes were found to enter damaged LLINs at night 
(31). Similarly, pyrethroid-resistant An. funestus mosqui-
toes have foiled indoor residual spraying efforts to control 
malaria parasite transmission in South Africa (8,36).
An. arabiensis mosquitoes were the predominant 
vector in Bondo, Rachuonyo, and Nyando (>90% of 
the An. gambiae s.l. population), the other vector being 
An. gambiae s.s mosquitoes. In Teso, An. gambiae s.s. 
mosquitoes were predominant (>70% of the An. gam-
biae s.l. population). It is therefore necessary that, even 
as programs continue to implement insecticide-based 
vector control, they follow the guidelines provided by 
global programs for insecticide resistance management 
(28). Regular insecticide resistance surveillance should 
continue to be conducted on a wide scale to ensure ac-
curate reporting of the otherwise largely heterogeneous 
insecticide resistance trends.
Our study had weaknesses that might have affected 
results, the first being the highly variable nature of the 
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Figure 1. Relationship between deltamethrin insecticide 
resistance and incidence of malaria parasite infection, 4 
subcounties, western Kenya, 2013 and 2014. The incidence 
of infection in the clusters from subcounties Bondo (blue), 
Ranchuonya (green), Nyando (red), and Teso (gray) in 
years 2013 (circles) and 2014 (Xs) were plotted against the 
corresponding values of mosquito mortality to deltamethrin for 
that year and that cluster. The best-fit line (with the 95% CI 
shaded in gray) for the scatterplot is nearly straight, suggesting 
no relationship between the incidence of infection and  
Anopheles gambiae sensu lato mosquito mortality upon 
exposure to deltamethrin measured by the World Health 
Organization bioassay.
Figure 2. Anopheles gambiae sensu lato mosquito mortality 
to deltamethrin, western Kenya, 2013 and 2014. Mortality was 
measured using the World Health Organization tube bioassay. 
Whiskers indicate full range of data; top and bottom lines of boxes 
indicate 25%–75% interquartile ranges; horizontal lines within 
boxes indicate medians.
 Insecticide-Treated Nets, Malaria, Western Kenya
susceptibility data from 1 year to the next and from 1 clus-
ter to the next. As mentioned previously, the WHO tube 
bioassay is not very informative of the intensity of insec-
ticide resistance. The categorization of net users and non–
net users might have substantially confounded results given 
that net use was not randomly assigned and non–net users 
were a relatively small number of children who did not pre-
fer to use nets. Last, our study did not consider insecticide 
resistance in the population of An. funestus mosquitoes, a 
reemerging vector in the region (37), mostly because of the 
difficulty of rearing them in the lab and finding them in 
larval habitats.
In conclusion, insecticide resistance, especially to 
pyrethroids, continues to increase in countries in sub-
Saharan Africa where LLINs and indoor residual spray-
ing are the mainstays of vector control. The results of 
this study indicate a utility for continuing LLIN use de-
spite the increasing levels of insecticide resistance in the 
malaria vector population. However, in our study, even 
among users of nets, malaria parasite incidence remained 
alarmingly high. Taken together with other reports sug-
gesting an increase in malaria prevalence in parts of 
western Kenya with high LLIN coverage (15,16), the 
malaria parasite transmission taking place in this region 
urgently needs to be addressed. Because of their reduced 
susceptibility, LLINs might not be killing mosquitoes as 
effectively as they used to. More emphasis needs to be 
placed on maximizing the coverage and use of LLINs, 
fully implementing the guidelines on resistance monitor-
ing, and developing more vector control tools to comple-
ment existing ones.
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EID Podcast: Musings on Sketches, Artists, and Mosquito Nets
James Abbott McNeill Whistler was born in Lowell, Massachusetts, on July 
11, 1834. When he was 9 years of age, his family moved to St. Petersburg, 
Russia, and there he studied drawing at the Imperial Academy of Science.
In Man at Table beneath Mosquito Net, Whistler himself might be the 
subject of this black ink drawing, part of a collection of such drawings from 
1854–55. Whistler captures the continued struggle of humans versus biting 
and stinging insects, including those that transmit vectorborne pathogens, 
from an intimate perspective.
Despite the mosquitoes teeming around him, the man is able to sketch 
intently and without worry, sheltered by the confines of his personal 
impenetrable veil. The flurry of cross-hatched, finely scrawled lines in 
these ephemera could be seen to mimic a mosquito’s flight path but this 
was simply a common technique that Whistler used in his sketches.
James Abbott 
McNeill Whistler 
(1834–1903) 
Man at Table 
beneath  
Mosquito Net, 
1854–55. 
Visit our website to listen: 
http://www2c.cdc.gov/podcasts/player.asp?f=8634428
